Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) Peptide
CLN8
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits CLN8
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- VFGVQSTAAG LWALLGDPVL HADKARGQQN WCWFHITTAT GFFCFENVAV
- Attributs du produit
- A synthetic peptide for use as a blocking control in assays to test for specificity of CLN8 antibody, catalog no. 70R-7115
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Antigène
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
- Synonymes
- mnd Peptide, C8orf61 Peptide, EPMR Peptide, CLN8, transmembrane ER and ERGIC protein Peptide, ceroid-lipofuscinosis, neuronal 8 Peptide, CLN8 Peptide, Cln8 Peptide
-
Vous êtes ici:
